| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Biochemistry and Pediatrics, University of Wisconsin Madison, Wisconsin 53706. The Department of Pediatrics, Montefiore Hospital and Medical Center, The Albert Einstein College of Medicine Cincinnati, Ohio 45226 The Food and Drug Research Laboratories, Food and Drug Administration Cincinnati, Ohio 45226
Address requests for reprints to: Hector F. DeLuca, Department of Biochemistry, 420 Henry Mall, University of Wisconsin, Madison, WI 53706.
The serum concentrations of the vitamin D metabolites 25-hydroxyvitamin D2 (25OHD2), 25-hydroxyvitamin D3 (25OHD3), and 1,25-dihydroxyvitamin D (calcitriol) have been measured in normal subjects whose ages varied from 18 months to 35 yr. Samples were obtained in all months of the year in order to assess the effects of season on serum concentration. During the months of April to September, 25OHD3 levels are higher than in the winter months. No seasonal variation in the 25OHD2 or calcitriol serum concentration was observed. Age-related differences in 25OHD2 and D3 concentrations did not exist. The levels of calcitriol are higher in adolescence and increase from 35 ± 19 pg/ml (SD) at 1.5–10 yr of age to 54 ± 21 pg/ml at 10–20 yr of age. In young adults, the levels fall again to 28 ± 16 pg/ml. Accordingly, despite a seasonal variation in the precursor of calcitriol, the levels of this most active metabolite of vitamin D do not change in relation to sunlight exposure. This lack of seasonal variation is further evidence of the tight feedback regulation of calcitriol.
* This work was supported by NIH Grants AM-14881, AM-19489, and ES-01060–06 from the PHS/DHEW, Food and Drug Administration Contract RFP 223–78225, and NASA Contract NAS9–15580
Received November 28, 1980.
This article has been cited by other articles:
![]() |
C. D Davis Vitamin D and cancer: current dilemmas and future research needs Am. J. Clinical Nutrition, August 1, 2008; 88(2): 565S - 569S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wu, S. Ren, L. Nguyen, J. S. Adams, and M. Hewison Splice Variants of the CYP27b1 Gene and the Regulation of 1,25-Dihydroxyvitamin D3 Production Endocrinology, July 1, 2007; 148(7): 3410 - 3418. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Garland, F. C. Garland, E. D. Gorham, M. Lipkin, H. Newmark, S. B. Mohr, and M. F. Holick The Role of Vitamin D in Cancer Prevention Am J Public Health, February 1, 2006; 96(2): 252 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Spach and C. E. Hayes Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice J. Immunol., September 15, 2005; 175(6): 4119 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Townsend, C. M. Banwell, M. Guy, K. W. Colston, J. L. Mansi, P. M. Stewart, M. J. Campbell, and M. Hewison Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue Clin. Cancer Res., May 1, 2005; 11(9): 3579 - 3586. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Young, G. G. Schwartz, L. Wang, D. P. Jamieson, L. W. Whitlatch, J. N. Flanagan, B. L. Lokeshwar, M. F. Holick, and T. C. Chen The prostate 25-hydroxyvitamin D-1{alpha}-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D Carcinogenesis, June 1, 2004; 25(6): 967 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Porter, H.L. Beynon, and H.S. Randeva Endocrine and reproductive manifestations of sarcoidosis QJM, August 1, 2003; 96(8): 553 - 561. [Full Text] [PDF] |
||||
![]() |
J Macdonald and H J Southgate Lessons to be learned: a case study approach: Sunshine-induced hypercalcaemia? Perspectives in Public Health, September 1, 2002; 122(3): 194 - 196. [Abstract] [PDF] |
||||
![]() |
P. B. Rapuri, H. K. Kinyamu, J. C. Gallagher, and V. Haynatzka Seasonal Changes in Calciotropic Hormones, Bone Markers, and Bone Mineral Density in Elderly Women J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2024 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Conron, C. Young, and H. L. C. Beynon Calcium metabolism in sarcoidosis and its clinical implications Rheumatology, July 1, 2000; 39(7): 707 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. John, G. G. Schwartz, D. M. Dreon, and J. Koo Vitamin D and Breast Cancer Risk: The NHANES I Epidemiologic Follow-up Study, 1971-1975 to 1992 Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 399 - 406. [Abstract] [Full Text] |
||||
![]() |
R. C. Henderson Vitamin D Levels in Noninstitutionalized Children With Cerebral Palsy J Child Neurol, October 1, 1997; 12(7): 443 - 447. [Abstract] [PDF] |
||||
![]() |
D. J. Margolis, M. Attie, and J. J. Leyden Effects of Isotretinoin on Bone Mineralization During Routine Therapy With Isotretinoin for Acne Vulgaris Arch Dermatol, July 1, 1996; 132(7): 769 - 774. [Abstract] [PDF] |
||||
![]() |
R. Marks, P. A. Foley, D. Jolley, K. R. Knight, J. Harrison, and S. C. Thompson The Effect of Regular Sunscreen Use on Vitamin D Levels in an Australian Population: Results of a Randomized Controlled Trial Arch Dermatol, April 1, 1995; 131(4): 415 - 421. [Abstract] [PDF] |
||||
![]() |
J. C. Netelenbos, M. J. M. Jongen, W. J. F. van der Vijgh, P. Lips, and F. C. van Ginkel Vitamin D Status in Urinary Calcium Stone Formation Arch Intern Med, April 1, 1985; 145(4): 681 - 684. [Abstract] [PDF] |
||||
![]() |
S. Dabbagh, R. W. Chesney, L. O. Langer, H. F. DeLuca, E. F. Gilbert, and J. H. DeWeerd Jr Renal-Nonresponsive, Bone-Responsive Pseudohypoparathyroidism: A Case With Normal Vitamin D Metabolite Levels and Clinical Features of Rickets Arch Pediatr Adolesc Med, November 1, 1984; 138(11): 1030 - 1033. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |